Orchid Pharma Limited (BOM:524372)
India flag India · Delayed Price · Currency is INR
997.45
+20.40 (2.09%)
At close: Aug 21, 2026

Orchid Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-832.11211.0736.01225.9743.07
Short-Term Investments
--0.160.1540.150.06
Cash & Short-Term Investments
832.11832.11211.2336.16266.1243.13
Cash Growth
-53.68%293.94%484.23%-86.41%517.08%-86.32%
Accounts Receivable
-2,6392,4181,9552,1521,706
Other Receivables
-8.6331.3848.071.580.01
Receivables
-2,6472,4502,0042,1541,706
Inventory
-2,5643,2642,6422,2871,727
Prepaid Expenses
--22.7822.1837.9171.18
Other Current Assets
-792.492,1263,203265.17429.94
Total Current Assets
-6,8398,0747,9085,0103,976
Property, Plant & Equipment
-9,5876,9646,3606,1925,931
Long-Term Investments
-527.11496.86458.4444.41454.98
Other Intangible Assets
-736.76170.14149.193.863.37
Other Long-Term Assets
-1,4201,174663.79601.97739.28
Total Assets
-19,10916,87915,53912,25211,106

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-2,2992,2212,2961,7441,677
Accrued Expenses
-1.32151.8131.62124.3140.03
Short-Term Debt
-297.51426.03140.481,410228.41
Current Portion of Long-Term Debt
----415.58369.47
Current Portion of Leases
-3.853.333.33--
Other Current Liabilities
-187.9953.6128.5525.8593.04
Total Current Liabilities
-2,7902,8562,6003,7192,408
Long-Term Debt
-3,2771,3161,2041,4882,082
Long-Term Leases
-47.250.373.7--
Pension & Post-Retirement Benefits
--4.0711.94101.1386.86
Long-Term Deferred Tax Liabilities
----32.2632.26
Other Long-Term Liabilities
-117.0429.824.424.8923.27
Total Liabilities
-6,2314,2063,8445,3664,632

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-507.19507.19507.19408.16408.16
Additional Paid-In Capital
--8,4658,4654,6454,645
Retained Earnings
---15,190-16,180-17,097-17,558
Comprehensive Income & Other
-12,37118,89118,90218,93118,979
Shareholders' Equity
12,87812,87812,67311,6956,8866,474
Total Liabilities & Equity
-19,10916,87915,53912,25211,106

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
3,6263,6261,7461,3523,3132,680
Net Cash (Debt)
-2,794-2,794-1,535-1,316-3,047-2,636
Net Cash Growth
------
Net Cash Per Share
-55.12-55.07-30.26-27.20-74.66-64.59
Filing Date Shares Outstanding
59.7150.750.7250.7240.8240.82
Total Common Shares Outstanding
59.7150.750.7250.7240.8240.82
Working Capital
-4,0495,2185,3081,2911,569
Book Value Per Share
253.98253.98249.86230.58168.72158.61
Tangible Book Value
12,14112,14112,50311,5456,8836,470
Tangible Book Value Per Share
239.45239.45246.51227.64168.62158.53
Land
--408.16256.47218.47122.87
Buildings
--1,8651,8491,7831,439
Machinery
--11,07110,77310,09710,095
Construction In Progress
--644.89163.94464.6397.84